JUNO DIAGNOSTICS
Juno Diagnostics is a health technology company democratizing access to high-value genetic information. The company is developing simple, cost-effective devices that enable point-of-need genetic testing. It was founded in 2017 and is based in San Diego, California.
JUNO DIAGNOSTICS
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2017-08-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.junodx.com
Total Employee:
11+
Status:
Active
Total Funding:
25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Adela
Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Cradle Genomics
Cradle Genomics is a creator of a novel prenatal testing methodology
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Exai Bio
Exai Bio is a next-generation Orphan non-coding RNAs and AI based liquid biospy company.
Foresight Diagnostics
Foresight Diagnostics develops novel technology created to detect cancers earlier from a simple blood draw.
Gestalt Diagnostics
Gestalt Diagnostics provides digital pathology using advanced technology, proven digital expertise and artificial intelligence.
GoodCell
GoodCell is a biotechnology company focused on personal bio-banking (storage) of stem cells, plasma & DNA and diagnostic genetic screening.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Luas Diagnostics
Luas Diagnostics is a platform technology on which it will develop accurate and affordable diagnostic tests.
Wellinks
Wellinks is a wearable health technology dedicated to improving clinical outcomes.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Jim Chauvapun COO @ Juno Diagnostics
COO
2017-08-01
Dirk van den Boom CEO @ Juno Diagnostics
CEO
2017-08-01
Jim Chauvapun Founder @ Juno Diagnostics
Founder
2017-08-01
Dirk van den Boom Founder @ Juno Diagnostics
Founder
2017-08-01
Founder
Investors List
Bioverge
Bioverge investment in Series A - Juno Diagnostics
Perceptive Advisors
Perceptive Advisors investment in Series A - Juno Diagnostics
Milad Alucozai
Milad Alucozai investment in Series A - Juno Diagnostics
Charge Ventures
Charge Ventures investment in Series A - Juno Diagnostics
Colle Capital Partners
Colle Capital Partners investment in Seed Round - Juno Diagnostics
Saltagen Ventures
Saltagen Ventures investment in Seed Round - Juno Diagnostics
Prototype Capital
Prototype Capital investment in Seed Round - Juno Diagnostics
Zoic Capital
Zoic Capital investment in Seed Round - Juno Diagnostics
Official Site Inspections
http://www.junodx.com Semrush global rank: 5.53 M Semrush visits lastest month: 1.54 K
Unable to get host informations!!!
More informations about "Juno Diagnostics"
Juno Diagnostics - Overview, News & Similar companies - ZoomInfo
Explore Complete Organization Structure. Is Juno Diagnostics your ideal costumer? Let us give you the heads up on whether it's a good time to reach out ... (JunoDx™), a company focused …See details»
JUNO DIAGNOSTICS STRENGTHENS THE ORGANIZATION WITH …
Oct 18, 2022 Prior to joining JunoDx, Ms. Grayum served as U.S. Sales Director, Women's Health, for Invitae, where she was responsible for leading the sales organization, overseeing …See details»
JUNO DIAGNOSTICS STRENGTHENS THE ORGANIZATION WITH …
SAN DIEGO, Oct. 18, 2022 /PRNewswire/ -- Juno Diagnostics (JunoDx), a company focused on bringing vital health information to patients by improvin...See details»
Juno Diagnostics Strengthens the Organization With ... - BioSpace
SAN DIEGO, Oct. 18, 2022 /PRNewswire/ -- Juno Diagnostics (JunoDx), a company focused on bringing vital health information to patients by improving access, affordability and …See details»
Juno Diagnostics - LinkedIn
Juno Diagnostics | 3,026 followers on LinkedIn. Prenatal Testing Reimagined | Juno Diagnostics supports growing families and their providers through every step of the pregnancy journey. …See details»
JUNO DIAGNOSTICS™ EXPANDS ITS PRODUCT PORTFOLIO WITH …
Jan 9, 2023 The JunoDx approach eliminates the need for traditional phlebotomy, a significant barrier to test access in many clinical settings. Juno Hazel™ screens for common …See details»
JUNO DIAGNOSTICS™ ANNOUNCES FORMATION OF CLINICAL …
SAN DIEGO, Jan. 5, 2023 /PRNewswire/ -- Juno Diagnostics™ (JunoDx™), a company focused on bringing vital health information to patients by improving access, affordability, and …See details»
JUNO DIAGNOSTICS ANNOUNCES APPOINTMENT OF TODD
SAN DIEGO, Oct. 6, 2022 /PRNewswire/ -- Juno Diagnostics (JunoDx), a company focused on bringing vital health information to patients by improving access, affordability and …See details»
Juno Diagnostics Announces Closing of $25 Million Series A …
May 12, 2021 JunoDx was founded by an experienced team who developed and launched the industry’s first NIPT product while at Sequenom. The Series A financing was closed following …See details»
JUNO DIAGNOSTICS ANNOUNCES PRESENTATION AT CREDIT …
SAN DIEGO, Oct. 25, 2022 /PRNewswire/ -- Juno Diagnostics™ (JunoDx™), a company focused on bringing vital health information to patients by improving access, affordability, and …See details»
Juno Diagnostics Raises $25M Series A - San Diego Business Journal
May 23, 2021 Founded in 2017, JunoDx is led by Boom and an experienced team who pioneered the development and commercialization of the first noninvasive cell-free DNA based …See details»
Zoic Capital Portfolio Company JunoDx Closes $25M Series A
Jun 4, 2021 – Funds will enable launch of prenatal noninvasive genetic testing. Seattle, WA – June 4, 2021 – Zoic Capital, a venture firm focused on early-stage medical technology …See details»
Juno Diagnostics Investment - Bioverge
Jul 14, 2021 JunoDx is doing groundbreaking work creating a simple at-home prenatal genetics test based on cell-free DNA. Prior to founding JunoDx, the team worked together at …See details»
JUNO DIAGNOSTICS™ EXPANDS ITS PRODUCT PORTFOLIO WITH …
Jan 9, 2023 The JunoDx approach eliminates the need for traditional phlebotomy, a significant barrier to test access in many clinical settings. Juno Hazel™ screens for common …See details»
JUNO DIAGNOSTICS ANNOUNCES APPOINTMENT OF TODD …
SAN DIEGO, Oct. 6, 2022 /PRNewswire/ -- Juno Diagnostics (JunoDx), a company focused on bringing vital health information to patients by improving access, affordability and …See details»
Juno Diagnostics™ Expands Its Product Portfolio With The Launch …
Jan 9, 2023 Juno Diagnostics™ (JunoDx™), a company focused on bringing vital health information to patients by improving access, affordability, and transparency, today announced …See details»
Genetic Testing Company JunoDx Launches Juno Hazel, Its Non …
Nov 18, 2022 Genetic testing company JunoDx has announced the launch of Juno Hazel, a new non-invasive prenatal screening (NIPS) solution enabled from finger-prick amounts of …See details»
JUNO DIAGNOSTICS™ ANNOUNCES ADDITIONAL COVERAGE OF …
SAN DIEGO, June 14, 2023 /PRNewswire/ -- Juno Diagnostics™ (JunoDx™), a company focused on bringing vital health information to patients by improving access, affordability, and …See details»
Juno Diagnostics introduces non-invasive prenatal screening …
Nov 18, 2022 JunoDx chief medical officer Mathias Ehrich said: “We spent the last few years building a foundation of exceptional science that catalysed the high performance of Juno …See details»
JUNO DIAGNOSTICS™ ANNOUNCES LAUNCH OF JUNO HAZEL™, …
SAN DIEGO, Nov. 17, 2022 /PRNewswire/ -- Juno Diagnostics™ (JunoDx™), a company focused on bringing vital health information to patients by improving access, affordability, and …See details»